BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 321116)

  • 21. Activation of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine to mutagens for V79 cells by isolated hamster and rat pancreatic acinar cells.
    Mangino MM; Scarpelli DG; Hollenberg PF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5219-24. PubMed ID: 4053002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicities of N-nitrosamines on Salmonella.
    Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T
    Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of co-cultivation of V79 cells with rat hepatocytes and rat H4IIE hepatoma cells for studying nitrosamine-induced hprt gene mutations.
    Swedmark S; Romert L; Beije B; Diaz-Pohl C; Bäckbro A; Jenssen D
    Mutagenesis; 1994 Jul; 9(4):281-7. PubMed ID: 7968567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assays for metabolic alpha-hydroxylation of N'-nitrosonornicotine and N-nitrosopyrrolidine and the influence of modifying factors.
    Chen CB; Hecht SS; McCoy GD; Hoffmann D
    IARC Sci Publ; 1980; (31):349-59. PubMed ID: 7228264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme specificity in the metabolic activation of N-nitrosodimethylamine to a mutagen for Chinese hamster V79 cells.
    Yoo JS; Yang CS
    Cancer Res; 1985 Nov; 45(11 Pt 1):5569-74. PubMed ID: 4053031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of N-hydroxy-2-aminofluorene bacterial mutagenicity by the soluble protein fraction from rat liver and partial purification of the enhancement activity.
    Saccone GT; DasGupta BR; Pariza MW
    Cancer Res; 1981 Nov; 41(11 Pt 1):4600-5. PubMed ID: 7030478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinol (vitamin A) inhibition of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN) induced sister-chromatid exchanges in V79 cells and mutations in Salmonella/microsome assays.
    Huang CC
    Mutat Res; 1987 Mar; 187(3):133-40. PubMed ID: 3547112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic activity in yeast assays of reputed nonmutagenic, carcinogenic N-nitroso compounds and methapyrilene hydrochloride.
    Mehta RD; von Borstel RC
    IARC Sci Publ; 1984; (57):721-9. PubMed ID: 6398305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P; Gingell R
    Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent DNA ruptures induced by the procarcinogen dimethylnitrosamine on primary rat liver cultures.
    Mendoza-Figueroa T; López-Revilla R; Villa-Treviño S
    Cancer Res; 1979 Aug; 39(8):3254-7. PubMed ID: 455308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of N-alkyl-N-(alpha-acetoxyalkyl) nitrosamines in V79 Chinese hamster cells in relation to alkylating activity.
    Huang GF; Mochizuki M; Anjo T; Okada M
    Gan; 1981 Aug; 72(4):531-8. PubMed ID: 7308664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity of N-nitrosodiethanolamine and its acetyl-derivatives [proceedings].
    Gilbert P; Rollmann B; Rondelet J; Mercier M; Poncelet F
    Arch Int Physiol Biochim; 1979 Oct; 87(4):813-4. PubMed ID: 93920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.